Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigation.
about
Utility of Genomic Assessment of Blood-Derived Circulating Tumor DNA (ctDNA) in Patients with Advanced Lung Adenocarcinoma.Impact of country of birth on genetic testing of metastatic lung adenocarcinomas in France: African women exhibit a mutational spectrum more similar to Asians than to Caucasians.Concordance between circulating tumor cells and clinical status during follow-up in anaplastic lymphoma kinase (ALK) non-small-cell lung cancer patients.
P2860
Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comprehensive genetic testing ...... ingle institute investigation.
@en
Comprehensive genetic testing ...... ingle institute investigation.
@nl
type
label
Comprehensive genetic testing ...... ingle institute investigation.
@en
Comprehensive genetic testing ...... ingle institute investigation.
@nl
prefLabel
Comprehensive genetic testing ...... ingle institute investigation.
@en
Comprehensive genetic testing ...... ingle institute investigation.
@nl
P2093
P2860
P356
P1433
P1476
Comprehensive genetic testing ...... ingle institute investigation.
@en
P2093
Aliya N Husain
Brian M Won
Cassie A Simon
Christopher H Wigfield
D Kyle Hogarth
Heber MacMahon
Janani Vigneswaran
Jeffrey Mueller
Kathryn Alexa Patton
Mark K Ferguson
P2860
P304
18876-18886
P356
10.18632/ONCOTARGET.7739
P407
P577
2016-02-26T00:00:00Z